The headline EPS beat was real, but it was not a clean demand-and-profitability beat. Adjusted EPS of $0.72 exceeded the published $0.61 consensus by $0.11, while revenue of $570.1 million missed the roughly $576.0 million expectation by $5.9 million. Organic sales returned to growth, but only 1.1%, and the core Wet Shave business still contracted. (Adjusted EPS reconciliation; Net Sales bridge; Segment net sales)
| Metric | Q3 FY2026 | Q3 FY2025 | Expectation / prior outlook |
|---|---|---|---|
| Net sales | $570.1M | $560.4M | ~$576.0M consensus |
| Organic sales growth | 1.1% | — | Return to growth, but modest (Net Sales bridge) |
| Adjusted diluted EPS | $0.72 | $0.72 | ~$0.61 consensus (Adjusted EPS reconciliation) |
| Adjusted operating income / margin | $53.0M / 9.3% | $63.6M / 11.3% | Down 200 bps year over year (Adjusted EPS reconciliation) |
| Adjusted EBITDA | $78.9M | $81.2M | Down 2.8% year over year (Adjusted EBITDA reconciliation) |
| FY26 adjusted EPS outlook | $1.80–$2.00 | — | Prior $1.70–$2.10; midpoint unchanged at $1.90 (Adjusted EPS Outlook) |
| FY26 adjusted EBITDA outlook | $250–$260M | — | Prior $245–$265M; midpoint unchanged at $255M (Adjusted EBITDA Outlook) |
Underlying profitability remains weaker than the flat EPS suggests. Adjusted operating margin fell to 9.3% from 11.3%, as inflation, tariffs, promotional mix, higher marketing, and higher SG&A outweighed productivity savings. Segment profit fell 10.0%, including a 20.9% decline in Wet Shave profit; Sun and Skin Care sales grew 5.7%, but its organic segment profit still slipped 1.6%. (Adjusted EPS reconciliation; Segment profit bridge)
Some of the quarterly earnings support was transitional rather than operating momentum. Other income included $7.7 million of Transition Services Agreement income following the Feminine Care divestiture, while lower debt reduced interest expense. That helped adjusted EPS hold flat year over year despite the lower operating margin and EBITDA. (Other income discussion; Adjusted EBITDA reconciliation)
Full-year guidance is effectively maintained at the midpoint, while the margin path has deteriorated. The adjusted EPS range narrows around the same $1.90 midpoint, roughly in line with the published $1.91 full-year consensus. But expected adjusted gross-margin expansion was cut to 20 basis points from 50, adjusted operating-margin decline widened to 80 basis points from 60, and expected restructuring charges rose to about $92 million from $90 million. The takeaway is a modestly better-than-expected quarter on EPS, but no material upgrade to the full-year earnings picture—and more acknowledgment that the recovery remains costly. (Fiscal 2026 Outlook; Adjusted EPS Outlook; Adjusted EBITDA Outlook)
Read the original 8-K on SEC EDGAR ↗